Cost effectiveness and ease of administration of low molecular weight heparin in deep vein thrombosis.
C P
CP
Teo
H L
HL
Lim
Y K
YK
Kueh
D000328:Adult; D000368:Aged; D003362:Cost-Benefit Analysis; D005260:Female; D006493:Heparin / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D017762:Nadroparin / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D010314:Partial Thromboplastin Time; D013924:Thrombophlebitis / Q000188:drug therapy* / Q000191:economics; D014859:Warfarin / Q000008:administration & dosage / Q000627:therapeutic use
D017762:Nadroparin; D014859:Warfarin; D006493:Heparin